GLP-1 Cost by State: Pricing Analysis of 9,580 Clinics (2026)

Medically reviewed by a licensed healthcare professional. Last updated March 2026.

About This Data

The numbers in this article come from our GLP-1 Clinic Data Report, which analyzed 9,580 active GLP-1 clinics across all 50 states. This is one of the largest datasets of its kind, and we update it regularly to reflect changes in clinic availability and pricing. All data was collected between January and March 2026.

The National Cost Picture

Looking for general GLP-1 pricing across medications and insurance scenarios? Start with our GLP-1 cost guide, which breaks down every option side by side. This article goes one layer deeper: how much GLP-1 treatment actually costs by state, based on the 424 clinics in our 9,580-clinic dataset that publicly report pricing.

The national average across those clinics falls between $350 and $857 per month. Why such a wide range? The lower end typically represents compounded semaglutide or tirzepatide from cash-pay telehealth providers. The upper end reflects brand-name medications like Wegovy or Zepbound at full retail or with minimal insurance coverage. Where you live changes which providers compete for your business, and that competition shapes the price you actually pay.

What Drives the Price Difference?

Several factors push your cost up or down:

• Medication type: Brand-name Wegovy (semaglutide) lists at approximately $1,349 per month. Zepbound (tirzepatide) lists at around $1,059. Compounded versions can run $200 to $500 per month.
• Insurance coverage: If your plan covers GLP-1 medications for weight management (not just diabetes), your copay could be as low as $25 to $75 per month. But many plans exclude weight loss coverage entirely.
• Clinic type: Weight loss specialty clinics and med spas often charge monthly program fees of $200 to $400 on top of medication costs. Telehealth providers tend to bundle everything into one monthly price.
• Dose: Higher doses cost more. As you titrate up over the first few months, your costs may increase.

State-by-State Clinic Availability

Clinic density varies enormously by state. More clinics generally means more competition and more options for patients, including lower prices.

States With the Most GLP-1 Clinics

The top three states alone account for over 30% of all GLP-1 clinics nationwide. If you live in a major metro area in California, Texas, or Florida, you likely have dozens of options within a short drive.

States With Fewer Options

Rural states like Wyoming, Montana, and the Dakotas have significantly fewer brick-and-mortar clinics. In these areas, telehealth becomes especially important. Many national telehealth platforms serve all 50 states, which helps bridge the access gap.

The Insurance Question

Our data shows that 95.6% of GLP-1 clinics accept some form of insurance. That sounds encouraging, but the reality is more complicated.

What "Accepts Insurance" Actually Means

A clinic accepting insurance does not guarantee your medication is covered. Here is how it breaks down:

• The clinic visit is usually covered under standard office visit codes, regardless of your plan.
• Lab work ordered during your visit is typically covered as diagnostic testing.
• The medication itself is where coverage gets tricky. Many commercial plans cover GLP-1 medications for type 2 diabetes but exclude them for weight management. Medicare Part D currently has limited coverage. Medicaid varies by state.

For a full breakdown of insurance coverage by plan type, visit our insurance guide.

Prior Authorization

Even when your plan technically covers GLP-1 medications, most insurers require prior authorization. This means your provider submits documentation proving medical necessity, and the insurer reviews it before approving coverage. The process typically takes 1 to 2 weeks but can take longer if an appeal is needed.

How to Find Affordable GLP-1 Treatment

Option 1: Use Insurance If You Have It

Start by calling your insurance company and asking specifically whether they cover semaglutide or tirzepatide for weight management. Get the answer in writing if possible. If they cover it, ask about your expected copay and whether prior authorization is required.

Option 2: Manufacturer Savings Programs

Both Novo Nordisk (Wegovy/Ozempic) and Eli Lilly (Zepbound/Mounjaro) offer savings cards for commercially insured patients. These can reduce your copay significantly, sometimes to $0 for the first few months.

Option 3: Compounded Medications

Compounding pharmacies produce custom formulations of semaglutide and tirzepatide, typically at much lower prices than brand-name versions. Monthly costs range from $200 to $500 depending on dose and pharmacy. These are legal and FDA-regulated, though they are not the exact same product as the brand-name version.

Option 4: Telehealth Providers

Online platforms often offer the most competitive all-in pricing because they bundle the consultation, medication, and shipping into one monthly fee. Many start at $199 to $399 per month for compounded options.

Check out our telehealth provider directory to compare options.

Option 5: Clinical Trials

Some patients qualify for clinical trials studying GLP-1 medications, which provide the medication free of charge. ClinicalTrials.gov lists active studies, and your provider can help you determine eligibility.

The Pricing Transparency Problem

One of the most striking findings from our analysis is how few clinics actually list their prices. Only 424 out of 9,580 clinics, roughly 4.4%, publicly share what patients can expect to pay. That forces patients to call multiple clinics, schedule consultations, and sometimes pay intake fees before learning the true cost.

We believe this needs to change. Transparent pricing helps patients make informed decisions and creates healthy competition among providers. Our clinic directory flags clinics that list pricing so you can prioritize those that are upfront about costs.

What to Watch for in 2026 and Beyond

Several trends could bring costs down over the coming year:

• Increased competition: New GLP-1 medications entering the market create pricing pressure on existing drugs.
• Manufacturer price cuts: Novo Nordisk has announced significant price reductions for Wegovy and Ozempic, effective January 2027.
• Expanding insurance coverage: More employers and insurers are adding GLP-1 medications to their formularies as the evidence for long-term health benefits grows.
• State-level action: Several states are considering legislation that would require insurers to cover FDA-approved weight management medications.

The Bottom Line

GLP-1 treatment costs anywhere from $200 to over $1,300 per month depending on your medication, insurance, and provider. The most important step you can take is to research your options before committing. Use our research data to understand the landscape, check your insurance coverage, and compare multiple providers.

The cheapest option is not always the best, and the most expensive is not always necessary. Focus on finding a provider who offers proper medical oversight, transparent pricing, and a treatment plan tailored to your needs.

Sources

1. GLP1Clinics.com Research Team. "GLP-1 Clinic Data Report: 2026 Analysis." GLP1Clinics.com. March 2026.
2. Novo Nordisk. "Wegovy Pricing and Savings Information." NovoCare.com. 2026.
3. Eli Lilly. "Zepbound Savings Card Program." LillyDirect.com. 2026.
4. Kaiser Family Foundation. "Coverage of Weight Loss Drugs in Medicare and Commercial Insurance." KFF.org. 2025.
5. Centers for Medicare and Medicaid Services. "Medicare Part D Formulary Guidelines." CMS.gov. 2025.